Skip to main content
. 2022 Sep 8;66(4):522–532. doi: 10.20945/2359-3997000000512

Table 4. Follow up strategies based on response to initial therapys.

Response to Therapy Recommended follow-up
Excellent Response Early decrease in the intensity and frequency of follow up and degree of TSH suppression
Low and intermediate risk:
Non stimulated Tg and TgAb every 12-24 months;
Consider neck US in 12-24 months, if negative, no need for further imaging
Indeterminate Response Decrease in the intensity and frequency of follow up and degree of TSH suppression
Active surveillance:
Serial imaging of non specific lesions;
Non stimulated Tg and TgAb every 12-24 months
Biochemical Incomplete Response Follow Tg curve with similar TSH levels.
Stable or declining Tg levels = Active surveillance
Non stimulated Tg and TgAb every 6-12 months,
Stimulated Tg if clinically indicated;
Neck US in 12 months.
TSH suppression (mild)
Increasing Tg or TgAb levels = Additional investigation
Individualized approach with anatomic, functional and/or hybrid imaging.
TSH suppression.
Structural Incomplete Response Individualized approach:
Consider actionable and non-actionable structural evidence of disease.
TSH suppression